×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • ORBIMED ADVISORS LLC (Data extracted from 13F, 13D, 13G and Form 4)

ORBIMED ADVISORS LLC

AUM: $18.21 B
13-F Portfolio Value: $4.26 B
Last 13-F Filed: Q3 2025
Concentration in top 10: 40.49%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
ABCLABCELLERA BIOLOGICS INC-3,344,568Exited13F
AGIOAGIOS PHARMACEUTICALS INC-557,900Exited13F
CPRXCATALYST PHARMACEUTICALS INC-416,900Exited13F
CGONCG ONCOLOGY INC (Call)-150,000Exited13F
CMMBCHEMOMAB THERAPEUTICS LTD-940,990Exited13F
CYTKCYTOKINETICS INC-1,077,000Exited13F
ENGNENGENE HOLDINGS INC-677,977Exited13F
IKNAIKENA ONCOLOGY INC-3,539,358Exited13F
INMBINMUNE BIO INC (Put)-50,000Exited13F
ITOSITEOS THERAPEUTICS INC-700,000Exited13F
PASGPASSAGE BIO INC-6,055,300Exited13F
THCTENET HEALTHCARE CORP-465,000Exited13F
THRDTHIRD HARMONIC BIO INC-5,779,071Exited13F
TSBXTURNSTONE BIOLOGICS CORP-3,099,265Exited13F
TYRATYRA BIOSCIENCES INC-804,603Exited13F
UNHUNITEDHEALTH GROUP INC-336,300Exited13F
UNHUNITEDHEALTH GROUP INC (Call)-50,000Exited13F
VRTXVERTEX PHARMACEUTICALS INC-210,287Exited13F
ZLABZAI LAB LTD-231,000Exited13F
LSBLAKESHORE BIOPHARMA CO LTD-54,799Exited13F